Replies to post #2726 on Galectin Therapeutics Inc. (GALT)

[gss2003]

I agree in general, but don't believe it will change and 2017 is really the critical year. Several possible catalysts:

- skin studies and partnership
- Immuno combo data and possible partnerships
- CX

So will wait it out